Angina is due to myocardial abrupt and transient ischemia and hypoxia caused by the clinical syndrome. Sense of angina is not really a lot like Daojiao general pain in the chest, but chest feel oppressed, plug the expansion, fever, etc., or feel like there are pressing or tightening pain in anterior part of heart, sternum, the disease process is likely to continue from 1 to 5 minutes, very few people more than 15 minutes, if not treated in time can cause acute myocardial infarction, sudden death, heart failure and other serious cardiovascular events.
Alleviate the effects of angina pectoris Tongluo better!

The main reason for angina

     Coronary artery is the heart of the supply of blood vessels, if the coronary blood supply is insufficient to meet the needs of myocardial metabolism, myocardial ischemia and anoxia would trigger angina. The most common coronary artery insufficiency is due to blocked coronary atherosclerotic plaque. However, there are still many such clinical patients, through a variety of checks, such as ECG, color Doppler ultrasound, and even coronary angiography did not find the phenomenon of coronary artery blockage, and no myocardial ischemia, but they are often angina pectoris, which the situation is most likely caused by coronary artery spasm, such as the temperature is too high or too low, vigorous exercise, emotional stimulation, etc. are prone to vasospasm, transient contraction of vascular spasm, which may cause transient myocardial ischemia and lack of of oxygen caused by angina. The occurrence of vasospasm has been mostly vascular endothelial injury, when there are rapid blood flow, or external factors, the impact of the stimulus when it is easy to spasm.

Medication and interventional treatment is still not alleviate many of angina pectoris

    Treatment of angina There are many, the most commonly used is the nitrates (such as nitroglycerin) and calcium channel blockers (such as Hexin cool). Nitroglycerin-type drugs is through relaxation of vascular smooth muscle, especially the small vascular smooth muscle, so that blood vessels expand to achieve the purpose to alleviate angina pectoris. But in recent years found that although these drugs can expand blood vessels, but vascular lesions, and there is no fundamental improvement in the role of Moreover, the expansion is only temporary in nature, so that some patients with angina after taking the drug still happen.

Hexin Shuang is the result of modern medical research found that with the expansion of coronary vascular spasm and the lifting of the drug, but later in the clinical practical application in some patients is still not alleviate the symptoms of angina.

In addition to medical treatment, angina symptoms, myocardial ischemia and severe coronary artery stenosis by coronary angiography showed that more than 70% of patients should be placed stent intervention. Involved in the success rate of 90% or more, but some still occur after interventional therapy in patients with angina pectoris, reason may be involved after the re-emergence of coronary artery stenosis, according to clinical statistics found that 25% -35% of the interventional therapy in patients with 3-6 months of this restenosis, recurrence of angina. Another reason is that coronary artery affected by temperature, exercise, emotional factors such as vascular spasm occurs after stimulation.

Tongluo can be lifted to clear blocked coronary vasospasm

Blocked coronary artery and coronary artery spasm is the main reason for angina, so the treatment is the key to open the blockage to relieve cramps, but traditional Chinese medicine meridians to clear the drug at the same time possesses two kinds of blood vessels and the lifting of the role of spasm. If selected Tongxinluo Huayu Capsule Tongluo the leech, Eupolyphaga insects, TPG and other drugs used to lower blood lipids, reducing deposition of lipids in the blood vessel wall to prevent the formation of atherosclerotic plaque, through the ablation to clear coronary artery-clogging plaque play a role in treatment of angina pectoris.

Tongxinluo capsule features the largest selection of the search for Scorpio Tongluo wind spasm, centipede, oneself, they are sharing the biggest advantage of the lifting of coronary artery spasm, spasm of the lifting mechanism is through improved vascular endothelial dysfunction, reduce the vasoconstrictor substance of endothelin (ET) levels, increased vasodilator substance nitric oxide (NO) levels, and thus play a regulating vasomotor functions.

Tongluo not only to clear blocked coronary arteries, and can lift the vascular spasm, so be sure to select traditional Chinese medicine treatment of angina medicine meridians.

     One study showed that treatment of angina pectoris drugs can ease some of aspirin, nitroglycerin and other similar drugs cause stomach discomfort. This discovery has important significance for patients with heart disease because they often also taking low-dose aspirin and nitroglycerin or similar drugs.

    From the University of Zaragoza, Spain Clinical Hospital led by Dr. Angel Lanas research team conducted a study, they have 1000 patients with bleeding ulcers and more than 2,000 patients hospitalized for other diseases were compared, the results published in the September 21, published in the New England Journal of Medicine. As the researchers expected, the majority of ulcer bleeding in patients hospitalized the week before a small dose of aspirin or other non-steroidal anti-inflammatory drug (NSAID) medication history.

     Known NSAIDs can cause stomach irritation and bleeding, so conventional medication arthritis patients are at high risk of stomach ulcers occur. The week before admission, about 11% of ulcers in patients taking low-dose aspirin, 46% of the intake of other types of NSAIDs.

      Report notes that, in general, taking low-dose aspirin are two-fold risk of ulcer bleeding, while taking other types of NSAID there are seven times more dangerous. However, while taking nitroglycerin or other similar drugs – Nitro-type vasodilator allows him to ulcer risk reduction 40%.

   Nitro class of vasodilators through the generation of nitric oxide (a type of vascular cell signaling molecules) causes the arteries to relaxation. Dr. Lanas study confirms the results of animal experiments to produce nitric oxide to protect NSAID medicines may cause damage.

Some patients with coronary heart disease that is commonly used anti-diarrheal medicine medicine, 3 does not work ate four or even more. As everyone knows, doing so toxins accumulate in the body, but to make the human body to increase the absorption of bacterial toxins, severe infections can lead to toxic shock and even death.
Coronary heart disease is far from the point of anti-diarrheal drugs

For many people, suffering from acute gastroenteritis diarrhea, diarrhea, diarrhea medicine, etc. eat their own, and soon will be able to solve the problem. However, these drugs are common in patients with coronary heart disease might be a “killer.”

Experts say, intestinal infection may cause fever, rapid heart rate, tenesmus, defecation and other reaction force, particularly in acute gastroenteritis caused by became very sick and did not think of diet not only increased the burden on the heart in patients with coronary heart disease and myocardial oxygen excess process, compounded by the body water loss, dehydration caused by the blood viscosity and increased the patients with myocardial ischemia is often induced by unstable angina, or even directly lead to acute myocardial infarction.

Some patients with coronary heart disease that is commonly used anti-diarrheal medicine medicine, 3 does not work ate four or even more. As everyone knows, doing so toxins accumulate in the body, but to make the human body to increase the absorption of bacterial toxins, severe infections can lead to toxic shock and even death.

Some patients are also not typical of myocardial infarction onset of epigastric pain, sometimes accompanied by mild diarrhea, enteritis treated in accordance with this moment, if simple, is bound to be adversely affected by illness, lose the best chance to save.

Abstract: The study found that a called abciximab of anticoagulant to stabilize a heart attack and reduce the effect of the mortality rate was disappointing.

Amsterdam, The Netherlands, (AP) The study found that doctors believe can contribute to rapid stabilization of a heart attack, reduce the mortality or morbidity as a anticoagulant disappointing. Drugs such as abciximab in patients with heart arteries interventional treatment, such as angioplasty to prevent clotting of blood cell adhesion to save lives, so that these operations even more safe and effective. Impressed with its effects, so researchers hope it can improve the prognosis of patients with non-surgical treatment. However, the study found that it does not have the slightest effect.

The European Heart Association meeting held on Monday announced the discovery. In a study of 7800 cases of severe chest pain caused by heart attack patients in an international study, all patients had mild anticoagulant quickly taking the role of aspirin and heparin, as a basis for therapeutic measures. These patients a high risk of heart attack because they did not completely block the blood flow in artery embolization.

In addition to aspirin and blood thinners, the half of the patients in 24 or 48 hours of intravenous abciximab, the other half entered a placebo. The study examined the first month to whether abciximab can reduce heart attack or death in patients with the opportunity. Did not use abciximab in patients treated with 8% of disease or death, the importation of the drug 24 hours and 48 hours of patients were 8.2% and 9.6% incidence.

The study’s principal member of the Erasmus University Hospital Rotterdam, the Netherlands (Erasmus University Hospital), Dr Maarten Simoons professor of medicine, said, “it does not show any benefit to patients.” At the same time, each group has about 2% of The patients need to lift artery embolization. Some researchers hope the drug will enable patients to avoid surgery or angioplasty. Simoons said, “some of us who think this is feasible. All of the data support that.”

Simoons, said the study found no effect of abciximab may be good because of its use has not yet to produce significant differences in the extent or timing of application of the drug too late. Abciximab in general in the preoperative and intraoperative application of 12 hours. New York, Mount Sinai School of Medicine (Mount Sinai School of Medicine), Professor Dr. Michael Farkouh, said the drug can still be carried out within a few hours artery surgery did not contribute to heart disease. But he added that, to some extent, the results of this study was not a surprise. “We have always maintained that these drugs are for interventional therapy in patients with the best choice,” he said, “That is all the evidence.”